GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Net Income From Continuing Operations

CTC Bio (XKRX:060590) Net Income From Continuing Operations : ₩-14,161 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. CTC Bio's net income from continuing operations for the three months ended in Mar. 2024 was ₩-284 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-14,161 Mil.

CTC Bio Net Income From Continuing Operations Historical Data

The historical data trend for CTC Bio's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio Net Income From Continuing Operations Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13,764.93 -22,868.29 -7,978.48 4,703.80 -15,587.90

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,711.32 -261.80 -2,543.32 -11,071.45 -284.01

CTC Bio Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-14,161 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTC Bio (XKRX:060590) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:011000 XKRX:053030 XKRX:048870 XKRX:397030 XKRX:115450 XKRX:083790 XKRX:048530 XKRX:086890 XKRX:199800 XKRX:278650 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
Website
http://www.ctcbio.com
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines